Physician profile
Devinder Singh Dhindsa
NPI 1265828610
$47,468.18
in general payments reported to CMS, 2019-2025
9 companies · $15K in 2025
The $15K reported for 2025 was more than what 86% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $4,362 · 2023: $14K · 2024: $14K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $17K · Food and Beverage: $12K · Consulting Fee: $8,796 · Grant: $4,900 · Education: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $17,278.01 |
| Food and Beverage | $11,760.38 |
| Consulting Fee | $8,796.31 |
| Grant | $4,900.00 |
| Education | $371.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $18,931.37 | 2022-2025 | Tacticath Ablation Catheter, Sensor Enabled, Aveir, Ensite Precision |
| Medtronic, INC. | $15,927.12 | 2022-2025 | Micra, Arctic Front Advance, Aurora Ev-Icd Mri Surescan |
| Philips North America LLC | $5,511.35 | 2024-2025 | (9520) Igt Devices Undivided, (Bh4) Igt Devices Undivided, (5028) Igt Devices Systems Undivided |
| Boston Scientific Corporation | $3,556.85 | 2022-2024 | Watchman, Watchman Flx |
| Biotronik INC. | $2,699.25 | 2023 | |
| Cardiva Medical, INC. | $345.19 | 2022 | |
| Biosense Webster, INC. | $269.08 | 2025 | Carto 3 |
| Atricure, INC. | $205.02 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.95 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devinder Dhindsa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.